Jupiter Neurosciences, Inc. Common Stock (JUNS) stock news · rev $21.8K
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
This JUNS news page leads with what Jupiter Neurosciences, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for JUNS yet. We will not pad this page with generic market recap.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the JUNS stock page; for the tape open the quote page.
JUNS stock news FAQ
What are JUNS's latest revenue and net income?
Latest cached Jupiter Neurosciences, Inc. Common Stock (JUNS) revenue for Dec 31, 2025 was $21.8K. Net income was -$8.6M. Statements: https://lician.com/financials/juns
What is JUNS's market cap?
Jupiter Neurosciences, Inc. Common Stock (JUNS) market cap is $10.0M on the latest cached fundamentals snapshot.
What kind of company is JUNS?
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
Where is JUNS stock news listed?
Cached stock news for Jupiter Neurosciences, Inc. Common Stock (JUNS) is listed at https://lician.com/news/juns. Filings: https://lician.com/sec/juns
Not investment advice.